Aggregatore di feed

(MedPage Today) -- Hospital employees' food purchases at work linked to obesity, diabetes, and cardiac problems

(MedPage Today) -- How can we make sure test results are communicated and followed up?

(MedPage Today) -- Also, should patients have access to their doctors' notes?

(MedPage Today) -- 'First study to demonstrate improved survival for a targeted therapy' in advanced disease

(MedPage Today) -- A nurse's case to limit phone use in hospitals

Alison Cameron had a successful nerve stimulation implant after injections and operations failed.

Janet Jenkins is one of 20 patients who have taken part in a research project into oesophageal cancer.

(MedPage Today) -- Monotherapy not superior in all patients, but topped EXTREME in PD-L1-positive groups

(MedPage Today) -- AOCD, AAD offer excellent educational apps

(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz

(MedPage Today) -- Most patients do not receive DMTs in the first year after diagnosis

(MedPage Today) -- Pembrolizumab leads to comparable survival outcomes versus chemo

(MedPage Today) -- More adverse events, no progression benefit with enzalutamide/abiraterone

(MedPage Today) -- This week's topics also include cholesterol guidelines and causes of death around pregnancy

(MedPage Today) -- Induction strategy improved 3-year overall survival in Chinese trial

(MedPage Today) -- Traditional risk factors like obesity and alcohol use don't fully explain unexpected increase among mostly young whites

Novartis has released data showing sharply improved overall survival rates for its breast cancer drug Kisqali, which the Swiss drugmaker hopes will help it chip away at the dominance of Pfizer's blockbuster Ibrance.

Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive after five years, according to data presented at a major medical meeting on Saturday.

(MedPage Today) -- Also: The multi-billion dollar cost of physician burnout

Julia Hartley-Brewer's invitation to speak at a conference was rescinded after doctors complained.